(Q43708616)

26 November 2017

Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study (English)

1 reference

26 November 2017

3

1 reference

26 November 2017

Vladyslav Nikolayevskyy

4

1 reference

26 November 2017

S Mironova

1

1 reference

26 November 2017

E Pimkina

2

1 reference

26 November 2017

Y Balabanova

5

1 reference

26 November 2017

G Skenders

6

1 reference

26 November 2017

T Kummik

7

1 reference

26 November 2017

F Drobniewski

8

1 reference

26 November 2017

25 October 2011

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

26 November 2017

1 reference

26 November 2017

31

1 reference

26 November 2017

7

1 reference

26 November 2017

1381-1387

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-011-1453-1

26 November 2017

0 references

cites work

Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Extensively drug-resistant tuberculosis: back to the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Multidrug-resistant tuberculosis detection, Latvia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

XDR Tuberculosis — Implications for Global Public Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1453-1

Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria

21 January 2018

1 reference

12 December 2020

Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients

1 reference

12 December 2020

Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam.

1 reference

12 December 2020

Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis.

1 reference

12 December 2020

Heteroresistance in Mycobacterium tuberculosis

1 reference

12 December 2020

10.1007/S10096-011-1453-1

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference